-
Vascular Health and Risk Management
-
About Dovepress
Open access peer-reviewed scientific and medical journals.
-
Open Access
Dove Medical Press is now a member of the Open Access Initiative
-
An Author's Guide
A guide to help authors get their paper published.
-
Advocacy
Support Open Access and Dove Press
-
Reprints
Promotional Article Monitoring - further details
-
Favored Author Program
Real benefits for authors, including fast-track processing of papers.
Prevalence and component analysis of metabolic syndrome: An Indian atherosclerosis research study perspective
Original Research
(2351) Views (717) Full article downloads
Authors: Saikat Kanjilal, Jayashree Shanker, Veena S Rao, Natesha B Khadrinarasimhaih, Manjari Mukherjee, et al
Published Date March 2008
Volume 2008:4(1) Pages 189 - 197
DOI: http://dx.doi.org/10.2147/VHRM.S2279
Saikat Kanjilal3, Jayashree Shanker1, Veena S Rao2, Natesha B Khadrinarasimhaih2, Manjari Mukherjee4, Shamanna S Iyengar3, Vijay V Kakkar1,5
1Mary and Garry Weston Functional Genomics Unit, Thrombosis Research Institute, Bangalore, India; 2Tata Proteomics and Coagulation Unit, Thrombosis Research Institute, Bangalore, India; 3Division of Cardiology, St. Johns Medical College and Hospital, Bangalore, India; 4University Department of Chemical Technology, Mumbai, India; 5Thrombosis Research Institute, Chelsea, London, UK
Abstract: Asian Indians have a high predisposition to metabolic syndrome (MS) and coronary artery disease (CAD). The present study aimed to estimate MS prevalence in 531 Asian Indian families comprising of 2318 individuals. Anthropometrics and lipid profile were assessed. MS prevalence was estimated using standard Adult Treatment Panel III (ATP-III) and World Health Organisation (WHO) criteria and modified definitions which included lowered cut-offs for waist circumference (WC) (≥90 cm for men and ≥80 cm for women], body mass index (BMI) (≥23 kg/m2) and impaired fasting glucose (IFG) levels. ATP-III criteria identified a significantly higher proportion of people with MS (N = 933; 40.3%) compared with WHO (N = 708; 30.6%; p<0.0001) while modified ATP-III showed maximum gain in percent prevalence among the revised criteria (17.3%; p = 0.0056). The IDF criteria identified similar proportion of subjects with MS (N = 809; 34.9%) as the revised WHO criteria (N = 792; 34.2%). The number of MS subjects was highest in the 50–59 years age group. MS was diagnosed a decade earlier in unaffected subjects compared with those with CAD/diabetes using the modified MS criteria. WC correlated significantly with BMI and waist–hip ratio (WHR) (p = 0.000). Among MS components, high density lipoprotein cholesterol and BMI contributed significantly in males (71.4% and 85.9%) and females (86.8% and 88.8%), respectively. The higher percentage contribution of WC among males and WHR among females indicates the influence of gynecoid/android pelvis on WHR measures. In conclusion, the revision of definition criteria for MS with lowered cut-offs for WC and BMI is critical for the accurate assessment of MS among Asian Indians.
Readers of this article also read:
Chronic heart failure in Japan: Implications of the CHART studies
Diagnosis and surgical approach of popliteal artery entrapment syndrome: a retrospective study
High density lipoprotein cholesterol: an evolving target of therapy in the management of cardiovascular disease
Application in the STRATHE trial of a score system to compare the efficacy and the tolerability of different therapeutic strategies in the management of hypertension
Editorial
Improvement of adenoviral vector-mediated gene transfer to airway epithelia by folate-modified anionic liposomes
Corrigendum
Erratum
A case of recurrent bloody tears
- Join ISVH
Be part of the World's leading experts in vascular health by joining the International Society of Vascular Health (ISVH)
- Testimonials
"... I was impressed at the rapidity of publication from submission to final acceptance." Dr Edwin Thrower, PhD, Yale University
- The western diet and lifestyle and diseases of civilization
- Stiffness of the large arteries in individuals with and without Down syndrome
- Effects of Azelnidipine plus OlmesaRTAn versus amlodipine plus olmesartan on central blood pressure and left ventricular mass index: the AORTA study
- Vascular effects of rapid-acting insulin analogs in the diabetic patient: a review




